BOVINE MASTITIS MARKET ANALYSIS

Bovine mastitis is a medical condition that is common in dairy cows. It refers to the inflammation of mammary gland and udder tissue. The disease can cause harm to the milk-secreting tissues in cows, which is one of the main reasons, it is considered as a dangerous condition. The increased global incidence of bovine mastitis is expected to have a positive impact on the overall market growth over the forecast period. When mastitis is discovered, the first aid is to apply ice cubes to the udder surface. Infected milk from diseased teats should be drained three times a day and disposed properly. To ensure hygienic disposal, a 5% phenol solution can be added to the infected milk.

Global bovine mastitis market is estimated to be valued at USD 1,562.9 Mn in 2024 and is expected to exhibit a CAGR of 5.2% during the forecast period (2024-2031).

Figure 1. Global Bovine Mastitis Market Value (USD Mn), By Region, 2024

To learn more about this report, request sample copy

Rising incidence of bovine mastitis is expected to drive the market growth over the forecast period.

The increasing incidence of bovine mastitis is expected to drive the market growth over the forecast period For instance, the global incidence of bovine mastitis ranges between 0 and 200 cows, according to the Cornell University College of Veterinary Medicine. Furthermore, the University of Glasgow estimates that bovine mastitis will cost between US$19.7 billion and $ 30 billion in annual healthcare costs, globally. Moreover, rising prevalence of bovine mastitis infections during the dry season, as well as the increased benefits of non-antibiotic intramammary products such as Teat Sealants in preventing new intramammary infections during the dry season, are expected to drive the market growth.

Figure 2. Global Bovine Mastitis Market Share, By Therapy, 2024

To learn more about this report, request sample copy

Recent Developments

In September 2022, Boehringer Ingelheim, a renowned global player in animal health, announced that the Clinical and Laboratory Standards Institute (CLSI) had endorsed enhanced interpretation criteria for Ubrolexin susceptibility testing. The Federation of Veterinarians of Europe (FVE) promotes the practice of conducting susceptibility testing whenever possible to determine the optimal antimicrobial treatment for a particular illness. The capacity to assess the susceptibility of a mastitis-specific antibiotic combination empowers veterinarians to select the optimal treatment, thereby, aiding in resistance prevention.

Increasing product launches for animal healthcare is expected to boost the market growth during the forecast period.

Cows are more susceptible to mastitis during dry off due to the environmental and physiological changes they go through. Because keratin plug growth changes throughout the dry period, a cow's natural barrier against new intramammary infections, pathogen risk is higher. When dry cows are exposed to high levels of environmental infections, National Mastitis Council's Recommended Mastitis Control Program recommends using a teat sealant. For instance, in February 2020 Merck & Co. Inc. announced the launch of Shut Out, a sterile, antibiotic-free barrier and a novel teat sealant solution. The product is intended to be used prior to dry off, in order to help avoid intramammary infections.

Global Bovine Mastitis Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency in 2020. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally as of August 2, 2021 are approximately 198,234,951 confirmed cases with around 4,227,359 deaths. The coronavirus or COVID-19 outbreak started from Wuhan, China and has spread across continents, affecting various industries globally.

Even during the epidemic, despite lockdown and social distancing procedures, the persistent demand for dairy products has surfaced in favor of the market growth. Moreover, as these products fall under the category of essential services, the market is estimated to grow rapidly during the forecast period.

Global Bovine Mastitis Market: Restraint

The increasing antibiotic resistance and lack of awareness about the bovine mestitis disease are the major factors that are expected to hinder growth of the global bovine mastitis market.

Key Players

Major players operating in the global bovine mastitis market include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.